| Bioactivity | Sulfisoxazole (Sulfafurazole) is an endothelin receptor antagonist with IC50 values of 0.60 μM and 22 μM against endothelin receptor A and endothelin receptor B, respectively. Sulfisoxazole is a sulfonamide antibacterial with an oxazole substituent. Sulfisoxazole inhibits breast cancer exosome release by targeting endothelin receptor A[1][2]. | ||||||||||||
| Name | Sulfisoxazole | ||||||||||||
| CAS | 127-69-5 | ||||||||||||
| Formula | C11H13N3O3S | ||||||||||||
| Molar Mass | 267.30 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Sulfisoxazole
CAS: 127-69-5 F: C11H13N3O3S W: 267.30
Sulfisoxazole (Sulfafurazole) is an endothelin receptor antagonist with IC50 values of 0.60 μM and 22 μM against endot
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.